奥普生物 (873758.oc)

+ 收藏

现金流量表(奥普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 208,029,015.3383,227,515.48133,524,609.5869,560,176.88
 收到的税费返还(元) 1,422,171.771,420,194.5832,218.693,145.57
 收到其他与经营活动有关的现金(元) 9,315,209.612,028,926.079,726,000.213,715,889.63
 经营活动现金流入小计(元) 218,766,396.7186,676,636.13143,282,828.4873,279,212.08
 购买商品、接受劳务支付的现金(元) 73,687,067.0632,516,609.1222,627,737.5716,573,526.19
 支付给职工以及为职工支付的现金(元) 66,897,705.9433,078,178.2757,886,185.0026,868,301.33
 支付的各项税费(元) 21,525,853.2813,422,122.2712,696,635.207,093,889.76
 支付其他与经营活动有关的现金(元) 32,592,947.1216,856,835.8827,265,165.3614,056,475.27
 经营活动现金流出小计(元) 194,703,573.4095,873,745.54120,475,723.1364,592,192.55
 经营活动产生的现金流量净额(元) 24,062,823.31-9,197,109.4122,807,105.358,687,019.53
二、投资活动产生的现金流量
 收回投资收到的现金(元) 78,696,789.1339,565,518.9011,500,000.00-
 取得投资收益收到的现金(元) 128,061.4289,904.9838,010.96-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 82,000.0080,000.00--
 投资活动现金流入小计(元) 78,906,850.5539,735,423.8811,538,010.96-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 3,093,174.431,481,369.103,967,084.881,816,457.89
 投资支付的现金(元) 76,090,000.0054,510,000.0024,600,000.002,000,000.00
 投资活动现金流出小计(元) 79,183,174.4355,991,369.1028,567,084.883,816,457.89
 投资活动产生的现金流量净额(元) -276,323.88-16,255,945.22-17,029,073.92-3,816,457.89
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 470,000.00470,000.0045,083,196.233,085,000.00
 筹资活动现金流入小计(元) 470,000.00470,000.0045,083,196.233,085,000.00
 分配股利、利润或偿付利息支付的现金(元) 20,008,265.5220,008,265.5280,243.50-
 支付其他与筹资活动有关的现金(元) 1,318,047.34190,000.00713,389.91-
 筹资活动现金流出小计(元) 21,326,312.8620,198,265.52793,633.41-
 筹资活动产生的现金流量净额(元) -20,856,312.86-19,728,265.5244,289,562.823,085,000.00
四、汇率变动对现金及现金等价物的影响(元) 722,478.961,385,474.852,624,274.611,403,390.03
五、现金及现金等价物净增加额(元) 3,652,665.53-43,795,845.3052,691,868.869,358,951.67
 加:期初现金及现金等价物余额(元) 156,000,877.50156,000,877.50103,309,008.64103,309,008.64
 期末现金及现金等价物余额(元) 159,653,543.03112,205,032.20156,000,877.50112,667,960.31
补充资料:
 净利润(元) 25,117,249.718,533,300.5617,231,539.8510,292,269.00
 资产减值准备(元) 847,865.35--453,730.994.65
 固定资产和投资性房地产折旧(元) 9,879,782.615,240,296.2911,967,745.795,294,121.06
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 9,879,782.615,240,296.2911,967,745.795,294,121.06
 无形资产摊销(元) 440,319.88218,537.52394,622.2277,571.90
 长期待摊费用摊销(元) 732,707.48407,266.81928,558.48338,402.31
 处置固定资产、无形资产和其他长期资产的损失(元) 260,501.25-68,362.8849,464.6871,596.50
 固定资产报废损失(元) 91,738.57-89,420.7272,248.70-
 公允价值变动损失(元) -397,618.22-8,492.58-86,394.32-
 财务费用(元) -654,152.10-1,365,160.38-2,544,550.14-2,057,436.45
 投资损失(元) -310,027.17-3,966,366.71-38,010.96-73,687.12
 递延所得税(元) -273,108.04--476,432.61550,344.52
  其中:递延所得税资产减少(元) -225,891.78--485,532.41560,768.92
 递延所得税负债增加(元) -47,216.26-9,099.80-10,424.40
 存货的减少(元) 277,887.66-1,873,119.94-3,709,435.23-2,793,502.01
 经营性应收项目的减少(元) 17,270,032.28-18,986,819.00-8,735,157.251,812,288.82
 经营性应付项目的增加(元) -31,040,711.403,347,859.887,084,769.08-4,824,953.65
 其他(元) --473,401.67--
 现金的期末余额(元) 159,653,543.03112,205,032.20156,000,877.50112,667,960.31
 减:现金的期初余额(元) 156,000,877.50156,000,877.50103,309,008.64103,309,008.64
 现金及现金等价物的净增加额(元) 3,652,665.53-43,795,845.3052,691,868.869,358,951.67
公告日期 2024-04-252023-08-182023-04-182023-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院